COMMUNIQUÉS West-GlobeNewswire

PathAI Launches Industry-Backed AIM-HI UC Model on GCP-Compliant Platform to Standardize Histological Assessment in Ulcerative Colitis Trials
23/09/2025
BOSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- PathAI, the global leader in AI-powered pathology, today announced the integration of AIM-HI UC 1 , an advanced AI model for Ulcerative Colitis (UC) histology endpoint [...]
LogicMark Launches Predictive Activity Metrics in Freedom Alert Max Device
23/09/2025
Revolutionary AI-powered technology shifts from reactive emergency response to proactive fall prevention through continuous health monitoring LOUISVILLE, Ky., Sept. 23, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: [...]
X-Chem Launches Chemomics: Applying Omics-Scale Chemistry Data to Yield New Candidate-Quality Molecules
23/09/2025
Intersection of best-in-class DEL, medicinal chemistry and innovative computation sciences launches era of high-throughput insights for drug discovery WALTHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- X-Chem, a global [...]
AAMI Foundation Awards Grants to Hospital, University Research Teams
23/09/2025
Grants will support research at Children's Hospital of Philadelphia, University of Maryland, University of Massachusetts Amherst Arlington, Virginia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The AAMI Foundation today [...]
Shotsy Names Eric Perakslis as Chief Science Officer to Advance Safe, Science-Backed GLP-1 Support
23/09/2025
Internationally recognized researcher in medical safety and privacy, former Chief Scientist (Informatics) and CIO at the FDA, brings scientific and regulatory leadership to Shotsy PORTLAND, Ore., Sept. 23, 2025 (GLOBE [...]
PridCor Therapeutics Principal Investigator Dr. David Putrino Participates in National Long COVID Roundtable Convened by Secretary Robert F. Kennedy Jr.
23/09/2025
TUSCALOOSA, Ala., Sept. 23, 2025 (GLOBE NEWSWIRE) -- PridCor Therapeutics today announced that Dr. David Putrino, principal investigator of the company’s SHIELD Study, participated in a national roundtable on Long COVID [...]
Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
23/09/2025
Highly secure, institutional-grade infrastructure supports Bitcoin, Ethereum and Solana treasury strategy SARASOTA, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a [...]
Tevogen Highlights Potential Role of TVGN 489 in Eliminating Persistent Viral Reservoirs Linked to Long COVID
23/09/2025
WARREN, N.J., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today highlights emerging scientific evidence linking persistent viral reservoirs to Long COVID, and [...]
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity
23/09/2025
MIAMI, FL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa
23/09/2025
HOUSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of [...]
Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
23/09/2025
Livestream Interview Can be Viewed on September 24th at 10:45am ET at Benzinga All Access Live HINGHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the [...]
Aphaia Pharma Publishes Phase 1 and 2 Clinical Data of Oral Formulation in Patients with Obesity and Prediabetes
23/09/2025
Aphaia’s lead formulation orchestrates a comprehensive hormonal response from nutrient-sensing cells with potential to modify the course of obesity and associated metabolic diseases. It is currently under evaluation in [...]
SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children
23/09/2025
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance Registry will be [...]
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
23/09/2025
Oral presentation will highlight the results from the randomized Phase 3 trial (IOB-013/KN-D18) of IO102-IO103 cancer vaccine plus pembrolizumab for first-line (1L) advanced melanoma Poster presentation will share final [...]
Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
23/09/2025
Company Provides Update on eAArly DETECT 2 Study BERKELEY, Calif. and MAINZ, Germany, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic [...]
Solid Biosciences Announces Licensing Agreement with Kinea Bio for the Use of Proprietary Next-Generation Capsid AAV-SLB101
23/09/2025
- Non-exclusive license for Solid’s proprietary, next generation capsid, AAV-SLB101, to accelerate development of Kinea Bio’s gene therapy for dysferlin-related limb-girdle muscular dystrophy - - Solid to receive an [...]
Vanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While Innovating
23/09/2025
COEP Balances Revenue Generation With Breakthrough Cell Therapy Development BRISTOL, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- VanderbiltReport.com , a financial news and content platform, reports that Coeptis [...]
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
23/09/2025
New program delivers TULSA Procedure’s precision treatment - minimal side effects, no overnight hospital stay – to Medicare patients across Texas TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. ( [...]
Hydrafacial Joins Cosmopolitan Readers’ Choice Hall of Fame as Three-Time Winner for Best Pro Facial
23/09/2025
This accolade builds on a year of major awards, reinforcing Hydrafacial’s proven results and trusted position with consumers and providers worldwide LONG BEACH, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- The Beauty [...]

Pages